173 related articles for article (PubMed ID: 29514883)
1. Adipose morphology and metabolic disease.
Tandon P; Wafer R; Minchin JEN
J Exp Biol; 2018 Mar; 221(Pt Suppl 1):. PubMed ID: 29514883
[TBL] [Abstract][Full Text] [Related]
2. Cellular Mechanisms Driving Sex Differences in Adipose Tissue Biology and Body Shape in Humans and Mouse Models.
Karastergiou K; Fried SK
Adv Exp Med Biol; 2017; 1043():29-51. PubMed ID: 29224089
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet-induced obesity regulates MMP3 to modulate depot- and sex-dependent adipose expansion in C57BL/6J mice.
Wu Y; Lee MJ; Ido Y; Fried SK
Am J Physiol Endocrinol Metab; 2017 Jan; 312(1):E58-E71. PubMed ID: 27879248
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction.
Laforest S; Labrecque J; Michaud A; Cianflone K; Tchernof A
Crit Rev Clin Lab Sci; 2015; 52(6):301-13. PubMed ID: 26292076
[TBL] [Abstract][Full Text] [Related]
5. Adipose angiotensin II type 1 receptor-associated protein ameliorates metabolic disorders via promoting adipose tissue adipogenesis and browning.
Luo C; Lv N; Chang Z; Qu Q; Huang J
Eur J Cell Biol; 2017 Sep; 96(6):567-578. PubMed ID: 28539232
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue dysfunction contributes to obesity related metabolic diseases.
Blüher M
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and impaired adipogenesis in hypertrophic obesity in man.
Gustafson B; Gogg S; Hedjazifar S; Jenndahl L; Hammarstedt A; Smith U
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E999-E1003. PubMed ID: 19622783
[TBL] [Abstract][Full Text] [Related]
8. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function.
Goossens GH
Obes Facts; 2017; 10(3):207-215. PubMed ID: 28564650
[TBL] [Abstract][Full Text] [Related]
9. The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity.
Jeffery E; Wing A; Holtrup B; Sebo Z; Kaplan JL; Saavedra-Peña R; Church CD; Colman L; Berry R; Rodeheffer MS
Cell Metab; 2016 Jul; 24(1):142-50. PubMed ID: 27320063
[TBL] [Abstract][Full Text] [Related]
10. Detrimental and protective fat: body fat distribution and its relation to metabolic disease.
Booth A; Magnuson A; Foster M
Horm Mol Biol Clin Investig; 2014 Jan; 17(1):13-27. PubMed ID: 25372727
[TBL] [Abstract][Full Text] [Related]
11. The color of fat and its central role in the development and progression of metabolic diseases.
Gaggini M; Carli F; Gastaldelli A
Horm Mol Biol Clin Investig; 2017 Sep; 31(1):. PubMed ID: 28942436
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.
Eriksson-Hogling D; Andersson DP; Bäckdahl J; Hoffstedt J; Rössner S; Thorell A; Arner E; Arner P; Rydén M
Int J Obes (Lond); 2015 Jun; 39(6):893-8. PubMed ID: 25666530
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
[TBL] [Abstract][Full Text] [Related]
14. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
[TBL] [Abstract][Full Text] [Related]
15. Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.
Moreno-Indias I; Tinahones FJ
J Diabetes Res; 2015; 2015():970375. PubMed ID: 25922847
[TBL] [Abstract][Full Text] [Related]
16. Visceral fat and insulin resistance - what we know?
Janochova K; Haluzik M; Buzga M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
[TBL] [Abstract][Full Text] [Related]
17. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
18. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women.
Michaud A; Boulet MM; Veilleux A; Noël S; Paris G; Tchernof A
Metabolism; 2014 Mar; 63(3):372-81. PubMed ID: 24369916
[TBL] [Abstract][Full Text] [Related]
19. A novel and robust method for testing bimodality and characterizing porcine adipocytes of adipose tissue of 5 purebred lines of pig.
Testroet ED; Sherman P; Yoder C; Testroet A; Reynolds C; O'Neil M; Lei SM; Beitz DC; Baas TJ
Adipocyte; 2017 Apr; 6(2):102-111. PubMed ID: 28425850
[TBL] [Abstract][Full Text] [Related]
20. Fat Cell and Fatty Acid Turnover in Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():135-160. PubMed ID: 28585198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
